prader willi glp 1 agonist Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management Prader–Willi Syndrome in Adults: An
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Merchenthaler I., Lane M., Shughrue P
This is not about labeling something as good or bad
These agents mimic the biological action of the native incretin hormone GLP-1 but are structurally modified to resist degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), thereby extending their half-life and duration of action (Zheng et al., 2024
doi: 10.1111/dom.1250.6
This avoids the weight regain risk of a full drug holiday
The insurance company reviewing the request
